Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 17, 2017Journal of Hematology & OncologyOpen Access

Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort

View Full Paper
Ask AI
Bookmark
Share

Authors

DJDarius JuškevičiusVilnius UniversityDJDavid JuckerUniversity of BaselDKDirk KlingbielUniversity of Geneva

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Juškevičius et al. (2017) studied this question.

synapsesocial.com/papers/6a9ef856a926c8a8b007b191https://doi.org/10.1186/s13045-017-0438-7
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E44942010 · 34 citations
  2. 2COSMIC: exploring the world's knowledge of somatic mutations in human cancer2014 · 2,419 citations
  3. 3Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies2014 · 1,208 citations
  4. 4Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era2010 · 1,644 citations
  5. 5An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era2013 · 970 citations